Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted delivery of antisense oligonucleotides to pancreatic β-cells
Carina Ämmälä, William J. Drury, Laurent Knerr, et al.
Science Advances (2018) Vol. 4, Iss. 10
Open Access | Times Cited: 159

Showing 1-25 of 159 citing articles:

Advances in oligonucleotide drug delivery
Thomas C. Roberts, Róbert Langer, Matthew J. A. Wood
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 10, pp. 673-694
Open Access | Times Cited: 1518
Glucagon-like peptide 1 (GLP-1)
Timo D. Müller, Brian Finan, Stephen R. Bloom, et al.
Molecular Metabolism (2019) Vol. 30, pp. 72-130
Open Access | Times Cited: 1318
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
Jin‐Kuk Kim, Chunguang Hu, Christelle Moufawad El Achkar, et al.
New England Journal of Medicine (2019) Vol. 381, Iss. 17, pp. 1644-1652
Open Access | Times Cited: 651
Antisense technology: an overview and prospectus
Stanley T. Crooke, Brenda F. Baker, Rosanne M. Crooke, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 6, pp. 427-453
Closed Access | Times Cited: 504
Lipids and Lipid Derivatives for RNA Delivery
Yuebao Zhang, Changzhen Sun, Chang Wang, et al.
Chemical Reviews (2021) Vol. 121, Iss. 20, pp. 12181-12277
Open Access | Times Cited: 403
Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
Suzan M. Hammond, Annemieke Aartsma‐Rus, Sandra Alves, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 4
Open Access | Times Cited: 259
Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug
Alexandre J. Debacker, Jon Voutila, Matthew C. Catley, et al.
Molecular Therapy (2020) Vol. 28, Iss. 8, pp. 1759-1771
Open Access | Times Cited: 253
Phosphorothioate modified oligonucleotide–protein interactions
Stanley T. Crooke, Timothy A. Vickers, Xue‐hai Liang
Nucleic Acids Research (2020) Vol. 48, Iss. 10, pp. 5235-5253
Open Access | Times Cited: 249
Antisense technology: A review
Stanley T. Crooke, Xue‐hai Liang, Brenda F. Baker, et al.
Journal of Biological Chemistry (2021) Vol. 296, pp. 100416-100416
Open Access | Times Cited: 237
Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus
Jing Yong, James D. Johnson, Peter Arvan, et al.
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 8, pp. 455-467
Open Access | Times Cited: 164
Metabolic Messengers: glucagon-like peptide 1
Fiona M. Gribble, Frank Reimann
Nature Metabolism (2021) Vol. 3, Iss. 2, pp. 142-148
Closed Access | Times Cited: 145
Oligonucleotide Therapeutics: From Discovery and Development to Patentability
Lara Moumné, Anne-Céline Marie, Nicolas Crouvezier
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 260-260
Open Access | Times Cited: 105
RNAi-based drug design: considerations and future directions
Qi Tang, Anastasia Khvorova
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 5, pp. 341-364
Open Access | Times Cited: 81
An autocatalytic multicomponent DNAzyme nanomachine for tumor-specific photothermal therapy sensitization in pancreatic cancer
Jiaqi Yan, Xiaodong Ma, Danna Liang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 75
Nucleic acid drug vectors for diagnosis and treatment of brain diseases
Zhiguo Lü, Jie Shen, H. J. Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 63
Frameworks for transformational breakthroughs in RNA-based medicines
John R. Androsavich
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 6, pp. 421-444
Closed Access | Times Cited: 27
Landscape of Noncoding RNA in Prostate Cancer
Junjie T. Hua, Sujun Chen, Housheng Hansen He
Trends in Genetics (2019) Vol. 35, Iss. 11, pp. 840-851
Closed Access | Times Cited: 137
Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle
Thazha P. Prakash, Adam E. Mullick, Richard Lee, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 12, pp. 6029-6044
Open Access | Times Cited: 118
The Interaction of Phosphorothioate-Containing RNA Targeted Drugs with Proteins Is a Critical Determinant of the Therapeutic Effects of These Agents
Stanley T. Crooke, Punit P. Seth, Timothy A. Vickers, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 35, pp. 14754-14771
Closed Access | Times Cited: 104
Antibody Conjugates-Recent Advances and Future Innovations
Donmienne Leung, Jacqueline Wurst, Tao Liu, et al.
Antibodies (2020) Vol. 9, Iss. 1, pp. 2-2
Open Access | Times Cited: 103
Sustainability Challenges and Opportunities in Oligonucleotide Manufacturing
Benjamin I. Andrews, Firoz D. Antia, Shawn B. Brueggemeier, et al.
The Journal of Organic Chemistry (2020) Vol. 86, Iss. 1, pp. 49-61
Open Access | Times Cited: 91
Selective tissue targeting of synthetic nucleic acid drugs
Punit P. Seth, Michael Tanowitz, C. Frank Bennett
Journal of Clinical Investigation (2019) Vol. 129, Iss. 3, pp. 915-925
Open Access | Times Cited: 88
Encoded Library Technologies as Integrated Lead Finding Platforms for Drug Discovery
Johannes Ottl, Lukas Leder, Jonas V. Schaefer, et al.
Molecules (2019) Vol. 24, Iss. 8, pp. 1629-1629
Open Access | Times Cited: 84
The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administration
Paymaan Jafar‐Nejad, Berit Powers, Armand Soriano, et al.
Nucleic Acids Research (2020) Vol. 49, Iss. 2, pp. 657-673
Open Access | Times Cited: 81
RNA Therapy: Current Status and Future Potential
Young‐Kook Kim
Chonnam Medical Journal (2020) Vol. 56, Iss. 2, pp. 87-87
Open Access | Times Cited: 79
Page 1 - Next Page

Scroll to top